Scholar Rock Holding Corp (SRRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SRRK | AMGN | VRTX | BMY | GILD |
| Company | Scholar Rock Holding Corp | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 26.49 | 277.67 | 462.80 | 56.50 | 87.63 |
| High | 27.50 | 281.60 | 463.90 | 58.65 | 88.60 |
| Low | 26.12 | 275.56 | 449.51 | 56.10 | 86.08 |
| Last | 27.50 | 279.29 | 448.15 | 58.26 | 87.79 |
| Change | +1.12 | +0.53 | -18.86 | +1.46 | -0.67 |
| % Change | +4.25% | +0.19% | -4.04% | +2.57% | -0.76% |
| Volume | 402,344 | 2,053,735 | 1,427,346 | 8,613,949 | 3,711,303 |
| 20-Day Average Volume | 925,630 | 2,588,414 | 1,227,526 | 11,855,274 | 7,432,269 |
| Previous Close | 26.38 | 278.76 | 467.01 | 56.80 | 88.46 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 28.44 | 310.06 | 481.40 | 55.42 | 90.78 |
| 20-Day Raw Stochastic | 25.50% | 8.50% | 0.58% | 70.33% | 13.57% |
| 20-Day Relative Strength | 57.09% | 28.01% | 40.61% | 61.29% | 49.20% |
| Weighted Alpha | -33.84 | -2.84 | +18.24 | +26.35 | +22.37 |
| Today's Opinion | 88% Buy | 40% Sell | 8% Sell | 100% Buy | 80% Buy |
| Previous Opinion | 88% Buy | 40% Sell | 32% Buy | 100% Buy | 80% Buy |
| Last Month's Opinion | 88% Buy | 8% Buy | 56% Buy | 72% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.84% since 11/12/24 | -6.29% since 11/12/24 | -7.98% since 11/12/24 | -1.17% since 11/12/24 | -6.89% since 11/12/24 |
| Low | 25.75 on 11/18/24 | 275.56 on 11/19/24 | 450.47 on 11/19/24 | 55.82 on 11/15/24 | 86.11 on 11/19/24 |
| High | 28.11 on 11/14/24 | 307.43 on 11/13/24 | 498.25 on 11/13/24 | 59.73 on 11/14/24 | 94.21 on 11/13/24 |
| 1-Month | |||||
| %Chg | -11.13% since 10/18/24 | -12.94% since 10/18/24 | -6.65% since 10/18/24 | +9.60% since 10/18/24 | +1.30% since 10/18/24 |
| Low | 25.75 on 11/18/24 | 275.56 on 11/19/24 | 450.47 on 11/19/24 | 51.81 on 10/28/24 | 85.60 on 10/22/24 |
| High | 31.24 on 10/29/24 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | +188.83% since 08/19/24 | -14.61% since 08/19/24 | -7.62% since 08/19/24 | +18.32% since 08/19/24 | +18.00% since 08/19/24 |
| Low | 6.76 on 10/03/24 | 275.56 on 11/19/24 | 447.70 on 10/07/24 | 46.88 on 08/22/24 | 74.34 on 08/20/24 |
| High | 35.38 on 10/08/24 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +117.37% since 05/17/24 | -10.38% since 05/17/24 | +1.27% since 05/17/24 | +32.48% since 05/17/24 | +29.73% since 05/17/24 |
| Low | 6.76 on 10/03/24 | 275.56 on 11/19/24 | 435.57 on 05/30/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 |
| High | 35.38 on 10/08/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,469,564 | 149,842,704 | 120,268,624 | 115,200,448 | 110,244,688 |
| Shares Outstanding, K | 93,615 | 537,533 | 257,529 | 2,028,177 | 1,246,266 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -165,790,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 2,771,900,000 | 11,892,000,000 | 7,545,000,000 |
| Last Quarter Net Income | -64,480,000 | 2,830,000,000 | 1,045,400,000 | 1,211,000,000 | 1,253,000,000 |
| 60-Month Beta | 0.47 | 0.60 | 0.39 | 0.44 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.66 on 11/12/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/12/24 | 10/30/24 | 11/04/24 | 10/31/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.600 on 10/04/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 10/04/24 | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.76 | 0.00 | 48.05 | 19.95 |